Clinical Trials Directory

Trials / Completed

CompletedNCT00963625

Comparison of Transfers of Fresh and Thawed Embryos in Normal Responder Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Fertility Center of Las Vegas · Industry
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study tests the hypothesis that controlled ovarian stimulation impairs endometrial receptivity in normal responders.

Detailed description

The purpose of this study is to determine if blastocyst transfers in cycles of post-thaw extended culture (PTEC) have different efficacy than transfers of fresh blastocysts in patients with expected normal response to ovarian stimulation. Multiple studies have found altered endometrial histology and gene expression following controlled ovarian stimulation. PTEC cycles require cryopreservation of the entire 2pn oocyte cohort in the prior cycle. Once thawed, the embryos are cultured to the blastocyst stage before transfer. In typical cycles using frozen-thawed embryos, many thawed embryos that appear to survive do not actually resume and continue development. PTEC ensures the transfer of embryos that resumed development and continued developing at least to the blastocyst stage (4-5 days post-thaw). The viability of a blastocyst in a PTEC cycle has been shown to be on par with that of a fresh blastocyst. Therefore, comparing outcomes of blastocyst transfers in PTEC cycles with that in fresh autologous cycles allows the potential endometrial impact of controlled ovarian stimulation to be assessed.

Conditions

Interventions

TypeNameDescription
PROCEDUREEmbryo cryopreservationCohort cryopreserved as bipronuclear (2pn) oocytes, then thawed and cultured to the blastocyst stage before transfer to the uterus.
PROCEDUREFresh blastocyst transferFresh blastocyst transfer following cycle of controlled ovarian stimulation.

Timeline

Start date
2007-10-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2009-08-21
Last updated
2010-10-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00963625. Inclusion in this directory is not an endorsement.